Surgery Partners, Inc. (SGRY)

Surgery Partners Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	2,743	2,539	2,225	1,860	1,831
Revenue Growth (YoY)	8.03%	14.12%	19.62%	1.57%	3.38%
Cost of Revenue	2,096	1,964	1,734	1,480	1,408
Gross Profit	647.5	574.9	491.4	379.8	423.8
Selling, General & Admin	120.9	102.2	104	97.1	88.6
Other Operating Expenses	197.3	125.1	87.4	110.5	97.8
Operating Expenses	318.2	227.3	191.4	207.6	186.4
Operating Income	329.3	347.6	300	172.2	237.4
Interest Expense / Income	193	234.9	221	201.8	178.9
Other Expense / Income	148.5	144	139.4	106.6	123.8
Pretax Income	-12.2	-31.3	-60.4	-136.2	-65.3
Income Tax	-0.3	23.3	10.5	-20.1	9.5
Net Income	-11.9	-54.6	-70.9	-116.1	-74.8
Preferred Dividends	0	0	10.3	39.5	35.7
Net Income Common	-11.9	-54.6	-81.2	-155.6	-110.5
Shares Outstanding (Basic)	126	92	72	49	48
Shares Outstanding (Diluted)	126	92	72	49	48
Shares Change	36.61%	26.96%	48.49%	1.03%	0.52%
EPS (Basic)	-0.09	-0.59	-1.12	-3.19	-2.29
EPS (Diluted)	-0.09	-0.59	-1.12	-3.19	-2.29
Free Cash Flow	230.8	91.1	35.5	262.5	73.5
Free Cash Flow Per Share	1.84	0.99	0.49	5.38	1.52
Gross Margin	23.60%	22.64%	22.08%	20.42%	23.14%
Operating Margin	12.00%	13.69%	13.48%	9.26%	12.96%
Profit Margin	-0.43%	-2.15%	-3.65%	-8.37%	-6.03%
Free Cash Flow Margin	8.41%	3.59%	1.60%	14.11%	4.01%
EBITDA	334.1	353.2	298.5	199.8	230.1
EBITDA Margin	12.18%	13.91%	13.42%	10.74%	12.56%
Depreciation & Amortization	153.3	149.6	137.9	134.2	116.5
EBIT	180.8	203.6	160.6	65.6	113.6
EBIT Margin	6.59%	8.02%	7.22%	3.53%	6.20%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).